Telesis Bio, Inc. Common Stock
TBIO
TBIO was delisted on the 27th of September, 2024.
10 hedge funds and large institutions have $2.05M invested in Telesis Bio, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 12 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
50% less funds holding
Funds holding: 20 → 10 (-10)
57% less capital invested
Capital invested by funds: $4.77M → $2.05M (-$2.71M)
83% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$417 |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$89 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$26 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$10 |
| 5 |
Citigroup
New York
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$184K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$36.8K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$29.5K |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$22.3K |
| 5 |
BlackRock
New York
|
-$10.9K |
TBIO Hedge Fund Activity: Q2 2024 in Review
10 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Telesis Bio, Inc. Common Stock (TBIO) for Q2 2024, worth a combined $2.05M — down 57% from $4.77M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TBIO and 2 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 7 added.
The largest buyer was UBS Group, adding an estimated $417. The largest seller was Vanguard Group, exiting entirely with an estimated $184K sold.
- 10 institutional investors held Telesis Bio, Inc. Common Stock (TBIO) as of Q2 2024, down from 20 in Q1 2024.
- Funds reported $2.05M of Telesis Bio, Inc. Common Stock stock for Q2 2024, down 57% quarter-over-quarter.
- 2 funds opened new Telesis Bio, Inc. Common Stock positions in Q2 2024 and 12 closed out, a net change of -10 holders.
- The largest Telesis Bio, Inc. Common Stock buyer in Q2 2024 was UBS Group, an estimated $417 added.
- The largest Telesis Bio, Inc. Common Stock seller in Q2 2024 was Vanguard Group, an estimated $184K sold.
Based on aggregated 13F filings for Q2 2024.